ALL CJC-1295

CJC-1295 – Injectable (2 mg × 10 Vials / 5 mg × 10 Vials / 10 mg × 10 Vials)

CJC-1295 is a synthetic growth hormone–releasing hormone (GHRH) analog engineered with modifications that increase stability and prolong biological activity. By stimulating pituitary release of growth hormone in a pulsatile pattern, CJC-1295 is widely used in research for its effects on muscle growth, recovery, fat metabolism, and overall endocrine function. Available in both DAC and non-DAC configurations, it provides flexible options for short-acting or extended-acting GH modulation.

Available Formats:

2 mg × 10 sterile vials (DAC)
5 mg × 10 sterile vials (DAC & non-DAC)
10 mg × 10 sterile vials (non-DAC)

Chemical Composition:

Type: GHRH analog
Variants: With DAC (extended half-life) / Without DAC (short-acting)
Molecular Weight:
• Without DAC: ~3.1 kDa
• With DAC: ~5 kDa

Administration (Injectable):

Supplied as a lyophilized peptide intended for subcutaneous injection after reconstitution with bacteriostatic water.
Non-DAC versions are commonly used in multiple daily pulses, while DAC versions support long-acting, once-weekly research protocols.

Benefits & Key Features:

Stimulates natural pulsatile GH release
Supports muscle growth, fat metabolism, and recovery
DAC version provides prolonged GH elevation
Non-DAC version enables physiologic GH pulse research
Highly stable lyophilized formula in sealed sterile vials

Product Notes:

For research and laboratory use only.
Must be reconstituted before administration.
Sterile, injectable-grade peptide.